CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway

References

• Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1:15021. doi:10.1038/nrdp.2015.21.
   PubMed Web of Science ®Google Scholar
• Fabian ID, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I, Ohnuma SI, Reddy MA, Sagoo MS. The management of retinoblastoma. Oncogene. 2018;37(12):1551–60. doi:10.1038/s41388-017-0050-x.
   PubMed Web of Science ®Google Scholar
• Teixo R, Laranjo M, Abrantes AM, Brites G, Serra A, Proenca R, Botelho MF. Retinoblastoma: might photodynamic therapy be an option? Cancer Metastasis Rev. 2015;34(4):563–73. doi:10.1007/s10555-014-9544-y.
   PubMed Web of Science ®Google Scholar
• Qian L, Yu S, Chen Z, Meng Z, Huang S, Wang P. The emerging role of circRNAs and their clinical significance in human cancers. Biochim Biophys Acta Rev Cancer. 2018;1870(2):247–60. doi:10.1016/j.bbcan.2018.06.002.
   PubMed Web of Science ®Google Scholar
• Ma Z, Shuai Y, Gao X, Wen X, Circular JJ. RNAs in the tumour microenvironment. Mol Cancer. 2020;19(1):8. doi:10.1186/s12943-019-1113-0.
   PubMed Web of Science ®Google Scholar
• Chen C, Huang Z, Mo X, Song Y, Li X, Li X, Zhang M. The circular RNA 001971/miR-29c-3p axis modulates colorectal cancer growth, metastasis, and angiogenesis through VEGFA. J Exp Clin Cancer Res. 2020;39(1):91. doi:10.1186/s13046-020-01594-y.
   PubMed Web of Science ®Google Scholar
• Lin S, Song S, Sun R, Zhang M, Du Y, Zhang D, Xu W, Wang H. Oncogenic circular RNA Hsa-circ-000684 interacts with microRNA-186 to upregulate ZEB1 in gastric cancer. Faseb J. 2020. doi:10.1096/fj.201903246R.
   Web of Science ®Google Scholar
• Lyu J, Wang Y, Zheng Q, Hua P, Zhu X, Li J, Li J, Ji X, Zhao P. Reduction of circular RNA expression associated with human retinoblastoma. Exp Eye Res. 2019;184:278–85. doi:10.1016/j.exer.2019.03.017.
   PubMed Web of Science ®Google Scholar
• O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402. doi:10.3389/fendo.2018.00402.
   PubMed Web of Science ®Google Scholar
• Delsin LEA, Salomao KB, Pezuk JA, Brassesco MS. Expression profiles and prognostic value of miRNAs in retinoblastoma. J Cancer Res Clin Oncol. 2019;145(1):1–10. doi:10.1007/s00432-018-2773-7.
   PubMed Web of Science ®Google Scholar
• Song L, Huang Y, Zhang X, Han S, Hou M, Li H. Downregulation of microRNA-224-3p hampers retinoblastoma progression via activation of the hippo-YAP signaling pathway by increasing LATS2. Invest Ophthalmol Vis Sci. 2020;61(3):32. doi:10.1167/iovs.61.3.32.
   PubMed Web of Science ®Google Scholar
• Ma X, Jin L, Lei X, Tong J, Wang R. MicroRNA3633p inhibits cell proliferation and induces apoptosis in retinoblastoma cells via the Akt/mTOR signaling pathway by targeting PIK3CA. Oncol Rep. 2020;43(5):1365–74. doi:10.3892/or.2020.7544.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wu S. microRNA −378a-3p Restrains the Proliferation of Retinoblastoma Cells but Promotes Apoptosis of Retinoblastoma Cells via Inhibition of FOXG1. Invest Ophthalmol Vis Sci. 2020;61(5):31. doi:10.1167/iovs.61.5.31.
   Web of Science ®Google Scholar
• Jung YS, Park JI. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond beta-catenin and the destruction complex. Exp Mol Med. 2020;52(2):183–91. doi:10.1038/s12276-020-0380-6.
   PubMed Web of Science ®Google Scholar
• Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020. doi:10.1038/s41580-020-0243-y.
   Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, Ge S. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6. doi:10.1186/s12943-018-0934-6.
   PubMed Web of Science ®Google Scholar
• Ng WL, Mohd Mohidin TB, Shukla K. Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018;15(8):995–1005. doi:10.1080/15476286.2018.1486659.
   PubMed Web of Science ®Google Scholar
• Guo N, Liu XF, Pant OP, Zhou DD, Hao JL, Lu CW. Circular RNAs: novel promising biomarkers in ocular diseases. Int J Med Sci. 2019;16(4):513–18. doi:10.7150/ijms.29750.
   PubMed Web of Science ®Google Scholar
• Zhao W, Wang S, Qin T, Wang W. Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3. J Cell Biochem. 2020. doi:10.1002/jcb.29631.
   Web of Science ®Google Scholar
• Chen NN, Chao DL, Li XG. Circular RNA has_circ_0000527 participates in proliferation, invasion and migration of retinoblastoma cells via miR-646/BCL-2 axis. Cell Biochem Funct. 2020. doi:10.1002/cbf.3535.
   Web of Science ®Google Scholar
• Xing L, Zhang L, Feng Y, Cui Z, Ding L. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway. Biomed Pharmacother. 2018;105:326–33. doi:10.1016/j.biopha.2018.05.141.
   PubMed Web of Science ®Google Scholar
• Jiang J, Zhang Y, Yu C, Li Z, Pan Y, Sun C. MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN. Cancer Cell Int. 2014;14(1):95. doi:10.1186/s12935-014-0095-7.
   PubMed Web of Science ®Google Scholar
• Shen F, Cai WS, Feng Z, Li JL, Chen JW, Cao J, Xu B. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression. Tumour Biol. 2015;36(3):1913–21. doi:10.1007/s13277-014-2794-z.
   PubMedGoogle Scholar
• von Frowein J, Hauck SM, Kappler R, Pagel P, Fleischmann KK, Magg T, Cairo S, Roscher A, von Schweinitz D, Schmid I. MiR-492 regulates metastatic properties of hepatoblastoma via CD44. Liver Int. 2018;38(7):1280–91. doi:10.1111/liv.13687.
   PubMed Web of Science ®Google Scholar
• Shi LP, Liang M, F F L, Li T, Lai DH, Xie QL, Yin YF, Liu YF. MiR-492 exerts tumor-promoting function in prostate cancer through repressing SOCS2 expression. Eur Rev Med Pharmacol Sci. 2019;23(3):992–1001. doi:10.26355/eurrev_201902_16986.
   PubMed Web of Science ®Google Scholar
• Wang K, Lu H, Qu H, Xie Q, Sun T, Gan O, Hu B. miR-492 promotes cancer progression by targeting GJB4 and is a novel biomarker for bladder cancer. Onco Targets Ther. 2019;12:11453–64. doi:10.2147/OTT.S223448.
   PubMed Web of Science ®Google Scholar
• Zhu L, Wang X, Wang T, Zhu W, Zhou X. miR4943p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway. Mol Med Rep. 2019;19(1):581–88. doi:10.3892/mmr.2018.9649.
   PubMed Web of Science ®Google Scholar
• He H, Liao X, Yang Q, Liu Y, Peng Y, Zhong H, Yang J, Zhang H, Yu Z, Zuo Y, et al. MicroRNA-494-3p promotes cell growth, migration, and invasion of nasopharyngeal carcinoma by targeting Sox7. Technol Cancer Res Treat. 2018;17:1533033818809993. doi:10.1177/1533033818809993.
   Web of Science ®Google Scholar
• Rosenbluh J, Wang X, Hahn WC. Genomic insights into WNT/beta-catenin signaling. Trends Pharmacol Sci. 2014;35(2):103–09. doi:10.1016/j.tips.2013.11.007.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang L, Qu Y. Targeting the beta-catenin signaling for cancer therapy. Pharmacol Res. 2020:104794. doi:10.1016/j.phrs.2020.104794.
   PubMed Web of Science ®Google Scholar
• Karim R, Tse G, Putti T, Scolyer R, Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology. 2004;36(2):120–28. doi:10.1080/00313020410001671957.
   PubMed Web of Science ®Google Scholar
• Takahashi-Yanaga F, Sasaguri T. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. J Pharmacol Sci. 2009;109(2):179–83. doi:10.1254/jphs.08r28fm.
   PubMed Web of Science ®Google Scholar